Imaging findings, clinical and pathological characters of 28 patients with Xp11.2/TFE3 translocation renal cell carcinoma

被引:7
作者
Dong, Haiping [1 ]
Ni, Yang [2 ]
Liu, Zhiling [3 ]
Wang, Zhou [4 ]
Hu, Bo [3 ]
Xu, Hongzhi [3 ]
Cai, Shifeng [3 ]
机构
[1] Fujian Matern & Child Hlth Hosp, Dept Radiol, Fuzhou, Fujian, Peoples R China
[2] Shandong First Med Univ, Dept Oncol, Shandong Prov Hosp, Jinan, Shandong, Peoples R China
[3] Shandong First Med Univ, Dept Radiol, Shandong Prov Hosp, 324 Jingwu Rd, Jinan 250021, Shandong, Peoples R China
[4] Shandong First Med Univ, Dept Pathol, Shandong Prov Hosp, Jinan, Shandong, Peoples R China
关键词
CT; imaging findings; MRI; renal cell carcinoma; Xp11.2RCC; GENE FUSION; COMPUTED-TOMOGRAPHY; NEOPLASMS; TFE3; PART;
D O I
10.4103/jcrt.jcrt_1505_22
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To analyze the imaging characteristics of Xp11.2/TFE3 translocation renal cell carcinoma and explore the relationship between the pathological features and imaging findings. Materials and Methods: Imaging, pathological, and clinical data of 28 patients with Xp11.2 RCC were studied from August 2013 to November 2019. The imaging characteristics and morbidity of different group were also explored meanwhile. Results: Patients ranged from 3 to 83 years old and the median age was 47 years. Bilateral renal tumors were detected in 1 patient and unilateral in the rest 27 patients. Out of 29 tumors, 13 were in the left kidneys and 16 in the right. Tumor size ranged from 2.2 cm x 2.5 cm to 20.0 cm x 9.7 cm. Tumors were cystic component/necrosis (29/29,100%), renal capsule breakage (16/29, 55%), capsule (18/29, 62%), calcification (15/29, 52%), fat (4/29, 14%), and metastasis (10/29, 34%). Tumors showed moderate enhancement during renal corticomedullary phase and delayed enhancement during nephrographic and excretory phase. The solid parts showed hypointense on T2WI. The imaging characteristics did not have significant correlation with the age, the incidence of adolescent and children group was higher than adult group. Conclusion: Xp11.2 RCC is a well-defined mass with cystic component, the solid part of tumor showed hypointense on T2WI. Xp11.2 RCC showed moderate enhancement during the renal corticomedullary phase and delayed enhancement during the nephrographic phase and excretory phase. Xp11.2 RCC has a higher incidence in children.
引用
收藏
页码:132 / 140
页数:9
相关论文
共 36 条
[1]   Active surveillance in renal tumors: Clinical and oncological outcomes [J].
Aguilera Bazan, Alfredo ;
Carrion, Diego M. ;
Gomez Rivas, Juan ;
Quesada-Olarte, Jose ;
Quintana, Luis M. ;
Alvarez-Maestro, Mario ;
Martinez-Pineiro, Luis .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (02) :414-419
[2]   Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations [J].
Altinok, G ;
Kattar, MM ;
Mohamed, A ;
Poulik, J ;
Grignon, D ;
Rabah, R .
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2005, 8 (02) :168-180
[3]   PRCC-TFE3 renal carcinomas -: Morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21) [J].
Argani, P ;
Antonescu, CR ;
Couturier, J ;
Fournet, JC ;
Sciot, R ;
Debiec-Rychter, M ;
Hutchinson, B ;
Reuter, VE ;
Boccon-Gibod, L ;
Timmons, C ;
Hafez, N ;
Ladanyi, M .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2002, 26 (12) :1553-1566
[4]   Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions -: A sensitive and specific immunohistochemical assay [J].
Argani, P ;
Lal, P ;
Hutchinson, B ;
Lui, MY ;
Reuter, VE ;
Ladanyi, M .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2003, 27 (06) :750-761
[5]   Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma -: A distinctive tumor entity previously included among renal cell carcinomas of children and adolescents [J].
Argani, P ;
Antonescu, CR ;
Illei, PB ;
Lui, MY ;
Timmons, CF ;
Newbury, R ;
Reuter, VE ;
Garvin, AJ ;
Perez-Atayde, AR ;
Fletcher, JA ;
Beckwith, JB ;
Bridge, JA ;
Ladanyi, M .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (01) :179-192
[6]   MiT family translocation renal cell carcinoma [J].
Argani, Pedram .
SEMINARS IN DIAGNOSTIC PATHOLOGY, 2015, 32 (02) :103-113
[7]   Xp11 Translocation Renal Cell Carcinoma (RCC): Extended Immunohistochemical Profile Emphasizing Novel RCC Markers [J].
Argani, Pedram ;
Hicks, Jessica ;
De Marzo, Angelo M. ;
Albadine, Roula ;
IlleiMd, Peter B. ;
Ladanyi, Marc ;
Reuter, Victor E. ;
Netto, George J. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2010, 34 (09) :1295-1303
[8]   Renal cell carcinoma in a 33-year-old male with an unusual morphology and an aggressive clinical course: possible Xp11.2 translocation [J].
Armah, Henry B. ;
Parwani, Anil V. .
PATHOLOGY, 2008, 40 (03) :306-308
[9]   Differential effect of body mass index by gender on oncological outcomes in patients with renal cell carcinoma [J].
Balci, Melih ;
Glaser, Zachary A. ;
Chang, Sam S. ;
Herrell, S. Duke ;
Barocas, Daniel A. ;
Keegan, Kirk A. ;
Moses, Kelvin A. ;
Resnick, Matthew J. ;
Smith, Joseph A. ;
Penson, David F. ;
Scarpato, Kristen ;
Clark, Peter E. .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (02) :420-425
[10]   Renal cell carcinoma, unclassified with unique features [J].
Chander, Bal ;
Preet, Kamal ;
Bharti, Ramesh ;
Deb, Prabal .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (04) :1097-1099